• Learning Objective 1: Describe the patient population that would benefit from a rate control strategy for atrial fibrillation
  • Learning Objective 2: Explain the risks of using non-dihydropyridine calcium channel blockers for atrial fibrillation in patients with heart failure with reduced ejection fraction
  • Learning Objective 3: Identify medications to utilize for rate control in patients with heart failure with reduced ejection fraction
Session date: 
Thursday, March 29, 2018 - 10:00am to 11:00am
Speaker Name: 
Meagan Sullivan, PharmD
Location: 
UCM
5841 S. Maryland Ave, MC 5068
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.